17.12.2004 – 16:43

euro adhoc: Sartorius AG
other
Ad-hoc-Announcement according to section 15 of the German WpHG / Sartorius AG will not take Vivascience AG public

Disclosure announcement transmitted by euro adhoc.
  The issuer is responsible for the content of this announcement.

The Executive Board and the Supervisory Board of Sartorius AG and
Vivascience AG decided not to carry out an IPO of Vivascience AG that
had originally been planned for 2001 and then postponed indefinitely.
The Sartorius Groups conviction about the business model and growth
opportunities of this business area remains unchanged. However,
considering the current capital market environment, the Group does
not see any possibility to realize profits from an IPO that would
sufficiently reflect this growth potential. Rather, this business
area is to be further expanded within the Sartorius Group and the
available synergies are to be increasingly used. The decision taken
does not have any impact on the sales revenue and earnings targets of
the Sartorius Group.

end of announcement                    euro adhoc 17.12.2004 16:06:50

Further inquiry note:

Heiko Imoehl
VP Treasury & Investor Relations
+49 551 308 4034

Branche: Biotechnology
ISIN: DE0007165607
WKN: 716560
Index: Prime Standard, CDAX, Prime All Share, Technologie All Share
Börsen: Berliner Wertpapierbörse / free trade
Hamburger Wertpapierbörse / free trade
Baden-Württembergische Wertpapierbörse / free trade
Börse Düsseldorf / free trade
Bayerische Börse / free trade
Bremer Wertpapierbörse (BWB) / free trade
Frankfurter Wertpapierbörse / official dealing
Niedersächsische Börse zu Hannover / official dealing

Weitere Storys: Sartorius AG

Alle Storys Alle

28.10.2004 – 08:36
euro adhoc: Sartorius AG / Nine-month earnings for 2004 already above full-year earnings for 2003 / Group sales revenue and order intake significantly up from the previous years level / Debt further reduced / Full-year targets unchanged
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. In the first nine-month period of 2004, the Sartorius Group increased its sales revenue by 3.9% (currency-adjusted: 6.6%) to 337.5 million from 324.8 million a year ago. We raised sales ...
mehr
29.07.2004 – 13:29
euro adhoc: Sartorius AG / Earnings substantially improved over last years / Group sales revenue above the previous years / Double-digit growth in order intake / Targets for 2004 unchanged / Long-term financing package agreed (E)
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. First-half sales revenue of the Sartorius Group rose 2.5% (currency-adjusted: 5.2%) to EUR222.3 million from EUR217.0 million a year ago. We increased sales revenue for the ...
mehr
29.04.2004 – 06:03
euro adhoc: Sartorius AG / Quarterly or Semiannual Financial Statements / First-quarter earnings substantially improved over the year-earlier quarter / Group sales revenue slightly above last years and, when currency-adjusted, significantly increased /
Disclosure announcement transmitted by euro adhoc. The issuer is responsible for the content of this announcement. The positive earnings development last reported by the Sartorius Group continued in the first quarter of 2004. Earnings before interest, taxes, depreciation and amortization, EBITDA, rose ...
mehr

euro adhoc: Sartorius AGotherAd-hoc-Announcement according to section 15 of the German WpHG / Sartorius AG will not take Vivascience AG public

euro_e_adhoc

Stock_markets

Wirtschaft

euro adhoc: Sartorius AG / Nine-month earnings for 2004 already above full-year earnings for 2003 / Group sales revenue and order intake significantly up from the previous years level / Debt further reduced / Full-year targets unchanged

euro adhoc: Sartorius AG / Earnings substantially improved over last years / Group sales revenue above the previous years / Double-digit growth in order intake / Targets for 2004 unchanged / Long-term financing package agreed (E)

euro adhoc: Sartorius AG / Quarterly or Semiannual Financial Statements / First-quarter earnings substantially improved over the year-earlier quarter / Group sales revenue slightly above last years and, when currency-adjusted, significantly increased /

euro adhoc: Sartorius AG
other
Ad-hoc-Announcement according to section 15 of the German WpHG / Sartorius AG will not take Vivascience AG public

euro adhoc: Sartorius AG / Nine-month earnings for 2004 already above full-year earnings for 2003 / Group sales revenue and order intake significantly up from the previous years level / Debt further reduced / Full-year targets unchanged

euro adhoc: Sartorius AG / Earnings substantially improved over last years / Group sales revenue above the previous years / Double-digit growth in order intake / Targets for 2004 unchanged / Long-term financing package agreed (E)

euro adhoc: Sartorius AG / Quarterly or Semiannual Financial Statements / First-quarter earnings substantially improved over the year-earlier quarter / Group sales revenue slightly above last years and, when currency-adjusted, significantly increased /